In this study, we analyzed the difference of gene expression profile of MSCs between newly diagnosed and relapsed MM patients, and found that the expression level of RAB22A in relapsed patients was significantly higher than that in newly diagnosed patients, and it was related to exosome-related genes and exosome scores. This evidence concerns the gene RAB22A and Miyoshi myopathy.